Online Inquiry
Cat.#: ACPP-1169
| Despition | proBNP Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1379 | Human OLFM1 Protein (AC1379) | 2 µg | inquiry |
| ACPP-1256 | Bestrophin Blocking Peptide (AC1256) | 250 µg | inquiry |
| ACPP-1611 | Human ICA69 Protein (AC1611) | 100 µg | inquiry |
| ACPP-1469 | Human S100A8 Protein (AC1469) | 5 µg | inquiry |
| ACPP-1657 | Human CRCP Protein (AC1657) | 5 µg | inquiry |
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1143 | Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.